Emphysema Treatment Global Market 2024 – By Size, Share, Trends, Demand, Forecast To 2033 | AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Novartis AG

The emphysema treatment market size is expected to see strong growth in the next few years. It will grow to $6.85 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%.  The growth in the forecast period can be attributed to aging population trends, customized treatment approaches, expanded access to therapies, focus on symptom management, collaborative healthcare models. Major trends in the forecast period include exploration of gene therapies, patient education and empowerment, integration of artificial intelligence (ai), increased accessibility to treatment, long-acting medications development.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/emphysema-treatment-global-market-report

Segmentation & Regional Insights
The emphysema treatment market covered in this report is segmented –
1) By Treatment: Smoking Cessation, Bronchodilators, Steroids, Leukotriene Modifiers, Supplemental Oxygen, Antibiotics, Gene Therapy, Surgery Transplant, Other Treatments
2) By Distribution Channel: Online Providers, Drug Stores and Retail Pharmacies, Hospital Pharmacies
3) By End-User: Clinics, Surgical Centre, Other End-Users

North America was the largest region in the emphysema treatment market in 2023. The regions covered in the emphysema treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10807&type=smp

Major Driver Impacting Market Growth
The rise in the prevalence of chronic obstructive pulmonary disease (COPD) cases is expected to propel the growth of the emphysema treatment market going forward. Chronic obstructive pulmonary disease (COPD) is a set of disorders that cause airflow obstruction and breathing difficulties, including emphysema and chronic bronchitis. Emphysema therapies are essential in reducing the advancement of Chronic Obstructive Pulmonary Disease (COPD) as they focus on treating symptoms, restoring lung function, and delaying disease progression. For instance, in September 2021, according to the study released by the Forum of International Respiratory Societies, a Switzerland-based respiratory health advocacy organization, an estimated 200 million people have COPD in 2021, with around 3.2 million dying each year, making it the third-leading cause of mortality globally. Therefore, the rise in the prevalence of chronic obstructive pulmonary disease (COPD) cases drives the emphysema treatment market.

Key Industry Players
Major companies operating in the emphysema treatment market report are AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Novartis AG, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Boehringer Ingelheim GmbH, Mylan N.V., Pfizer Inc., Orion Oyj, Verona Pharma PLC, Pulmonx Corporation, Bioxyne Limited, Intrexon Corporation, iCure Pharmaceuticals Inc., Kamada Ltd., Emphasys Medical Inc., Halozyme Therapeutics Inc., Mariposa Health Limited, Uptake Technologies Inc., British Technology Group International , Astellas Pharma Inc., Respinova Ltd, Gala Therapeutics Inc., Pulmatrix Inc., Broncus Medical Inc., Holaira Inc., PneumRx Inc., Spiration Inc., Aeris Therapeutics Inc., CSA Medical Inc., Olympus Corporation

The emphysema treatment market report table of contents includes:
1. Executive Summary
2. Emphysema Treatment Market Characteristics
3. Emphysema Treatment Market Trends And Strategies
4. Emphysema Treatment Market – Macro Economic Scenario
5. Global Emphysema Treatment Market Size and Growth
………………………..
31. Global Emphysema Treatment Market Competitive Benchmarking
32. Global Emphysema Treatment Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Emphysema Treatment Market
34. Emphysema Treatment Market Future Outlook and Potential Analysis
35. Appendix

Explore the trending research reports from TBRC:
https://goodprnews.com/blood-processing-devices-and-consumables-global-market-size/
https://goodprnews.com/bubble-tea-global-market-size/
https://goodprnews.com/caraway-seeds-global-market-size/
https://topprnews.com/blood-processing-devices-and-consumables-global-market-share/
https://topprnews.com/bubble-tea-global-market-share/
https://topprnews.com/caraway-seeds-global-market-share/

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model